GE Healthcare Technologies, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
2,581.00
2,361.00
2,512.00
2,875.00
2,710.00
2,091.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-133.00
196.00
-95.00
-1,278.00
87.00
-409.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,951.00
2,101.00
2,113.00
1,607.00
1,687.00
1,989.00
Cash Flow from Investing Activities
-914.00
-558.00
-398.00
-1,761.00
19,986.00
-325.00
Cash Flow from Financing Activities
-573.00
-478.00
-822.00
-263.00
-21,544.00
-1,574.00
Net Cash Inflow / Outflow
387.00
1,055.00
890.00
-451.00
143.00
35.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-77.00
-10.00
-3.00
-34.00
14.00
-55.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of GE Healthcare Technologies, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
2581
1521
1,060.00
69.69%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-133
83
-216.00
-260.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1951
1751
200.00
11.42%
Cash Flow from Investing Activities
-914
-1258
344.00
27.34%
Cash Flow from Financing Activities
-573
-752
179.00
23.80%
Net Cash Inflow / Outflow
387
-261
648.00
248.28%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-77
-2
-75.00
-3750.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -7.14% vs -0.57% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,951.00
2,101.00
-7.14%






